About Globin Solutions
Globin Solutions is a company based in Pittsburgh (United States) founded in 2017. Globin Solutions has raised $5 million across 2 funding rounds from investors including UPMC, HHS and TusPark. Globin Solutions offers products and services including Antidotal Therapies. Globin Solutions operates in a competitive market with competitors including GSK, eGenesis, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
- Headquarter Pittsburgh, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Globin Solutions, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5 M (USD)
in 2 rounds
-
Latest Funding Round
$1.73 M (USD), Grant
Feb 01, 2020
-
Investors
UPMC
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Globin Solutions
Globin Solutions offers a comprehensive portfolio of products and services, including Antidotal Therapies.
Develops treatments for human poisonings using globin chemistry.
People of Globin Solutions
Unlock access to complete
Unlock access to complete
Leadership Team
3 people
Program Team
1 people
Board Team
1 people
Finance and Accounting
1 people
Chairman Team
1 people
Unlock access to complete
Funding Insights of Globin Solutions
Globin Solutions has successfully raised a total of $5M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.73 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Globin Solutions
Globin Solutions has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include UPMC, HHS and TusPark.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
TusPark is operated as a science park and innovation ecosystem facilitator.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Multispecialty hospitals are operated as a nationwide chain.
|
Locked | Locked | Locked |
Investor details for Globin Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Globin Solutions
Investment portfolio details for Globin Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Globin Solutions
Detailed financials for Globin Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Globin Solutions Comparisons
Peer comparison for Globin Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Globin Solutions
Globin Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, eGenesis, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
Detailed competitors of Globin Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Globin Solutions
Complete news archive for Globin Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Globin Solutions
Globin Solutions was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Globin Solutions is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Globin Solutions is a funded company, having raised a total of $5M across 2 funding rounds to date.
Globin Solutions was founded in 2017 and is based in Pittsburgh, United States. The company operates in the biotechnology sector, focusing on antidotal therapies for human poisonings. Its technology centers on neuroglobin (Ngb), a hemoglobin-like protein present in the brain. A genetically engineered variant, Ngb H64Q, has been developed to enhance carbon monoxide scavenging capabilities.
Globin Solutions's top competitors include Sutro Biopharma, Synthego and eGenesis.
Globin Solutions offers Antidotal Therapies.